Please enable JavaScript to view the comments powered by Disqus.

Fund Watch

Sequoia Fund Tries to Recover from Valeant Misstep

Damaged by a huge bet gone awry, a fund once endorsed by Warren Buffett seeks to regain its glory.

Thinkstock

The view of Central Park from the 50th floor of a midtown Manhattan skyscraper is breathtaking. The office is home to Ruane, Cunniff & Goldfarb, which runs Sequoia Fund (symbol SEQUX), a 46-year-old mutual fund with a once-great record and ties to Warren Buffett. The firm moved in two years ago, fulfilling a dream of its then-CEO, Robert Goldfarb.

See Also: 105 Most Popular Funds for Your Retirement Savings

But Goldfarb is no longer around to enjoy the view. He resigned in March after the fund suffered huge losses because of a large and ultimately misplaced bet on Valeant Pharmaceuticals, which at one point accounted for 32% of the fund’s assets. The stock plunged 93% from August 2015 to June 2016 as the controversial drug maker faced scrutiny over its business practices. Over that period, Sequoia fell 34%, lagging Standard & Poor’s 500-stock index by 31 percentage points.

The stumble underscored the risks of concentrated portfolios—Sequoia normally holds only 20 to 40 stocks—and stained an otherwise solid record. For example, from the start of 2000 through July 2015, Sequoia earned 10.1% annualized, crushing the S&P 500 by an average of 5.8 percentage points per year. Valeant’s soaring share price helped Sequoia beat the market from 2011 through 2013, a feat that only one-third of actively managed U.S. funds could claim. It seemed that Buffett had made the right call when, in the course of liquidating his investment partnership, he suggested that his clients invest with his friend Bill Ruane, who, with Richard Cunniff, would launch Sequoia in 1970.

The founding managers didn’t live to see the recent chaos. Between October 2015 and August 2016, two members of the fund’s board resigned. Shareholders pulled $1.9 billion more from Sequoia than they added and filed lawsuits against both the fund and the management firm. Sequoia’s assets, $9.3 billion at their peak, now stand at $4.8 billion.

Advertisement

Last March, David Poppe, Sequoia’s comanager since 2006, was promoted to CEO of the management firm. He named four new comanagers, all longtime analysts at the firm. The new team quickly altered the decision-making process for buying and selling stocks. During Goldfarb’s tenure, he, Poppe and the analyst who covered a stock had to agree unanimously before Sequoia could buy or sell a single share. The new team decreed that a four-to-one vote among them would be sufficient to take action, “so that one person can’t paralyze the process,” says Poppe.

The subtext, of course, is that Goldfarb was responsible for blocking disposal of Valeant stock even as the firm’s woes were mushrooming. Says Poppe: “That’s where we got in trouble, where Bob said, ‘I’m right and you guys are wrong.’ The problem was that the one time Bob was really wrong was on the biggest position in the portfolio.” With Goldfarb gone, the five managers unanimously agreed to sell all of the Valeant shares. The deed was done by June. (Goldfarb declined to comment.)

Comanager John Harris says he and his colleagues practice “gumshoe journalism” when they investigate com­panies, peppering customers, rivals, suppliers and employees (current and former) with questions. Not surprisingly, their ranks include several former journalists—including Poppe, once a reporter for the Miami Herald, as well as veteran analyst Greg Steinmetz, a one-time London bureau chief for the Wall Street Journal.

The managers seek high-quality, growing companies with a sustainable competitive edge in their industry and a smart and trustworthy CEO. They buy when prices are reasonable relative to a company’s growth potential. “We’re not bargain hunters,” says comanager Trevor Magyar. “We’re just very careful purchasers of high-quality businesses.”

Advertisement

Sequoia has a long way to go to mend its reputation. One notch in its favor is that, aside from the departures of Goldfarb and the analyst who covered Valeant, the team that has picked stocks for the past decade remains intact. The fund does not levy a sales charge, and annual fees, at 1%, are below average. We’re not ready to endorse Sequoia, but we will be watching it closely in the coming months.

See Also: How to Buy American Funds Without a Sales Charge